Pairwise comparisons of response rates and 95% CIs for ORs between each sarilumab dose and placebo were derived by testing each active dose group versus placebo separately.
Pairwise comparisons for the response rates between each dose of sarilumab and placebo were derived by testing each active dose group versus placebo separately.
The main improvement in the testing strategy would be to conduct a better investigation of the dose-response relationship by testing more doses, especially in the lower dose range, as it was proposed during the workshop on "The low dose effects and non-monotonic dose responses for endocrine active chemicals: Science to practice", held in Berlin, Germany, on September 12 14th , 2012[ 79].
The Mantel-Haenszel estimate of the OR and the corresponding 95% CI were derived by testing each active dose group versus placebo separately.
We have extended previous studies (Chikwamba et al. 2003; Karaman et al. 2006) by testing doses of 0.0002, 0.002, 0.02, 0.2, 2, and 20 μg LT-B for serum IgG and IgA as well as fecal IgA and we have observed a dose-dependent antibody response.
You can test its effectiveness by giving an oral dose and then taking a short car ride 30 minutes later.
By testing a 16-fold dose range, this study also found that the most effective dose (4 µg/kg of body weight) is about 1,000 times smaller than the commercially available form for its FDA-approved indication.
By testing different concentrations, a dose-dependent antiprion effect was observed indicating that GA is active in the low micromolar range against PrPSc in the MovS6 cell-based system (Figure 2, panel b, upper gel).
Clinicians are now able to minimize the risk of prescribing the wrong dose by testing a patient's genome for relevant variants in order to establish the appropriate dosage of medications, thereby making treatment more effective [ 58].
The implementation was then validated by testing the population response to multi-dose anti-PCSK9 both as a monotherapy and in combination with atorvastatin.
